Has Angiodynamics, Inc. had product recalls?

Yes, 20 recalls on file. See the full history below for each one.

Is this FDA enforcement data for Angiodynamics, Inc. official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Angiodynamics, Inc. had?

Argus HQ has recorded 20 FDA events for Angiodynamics, Inc.: 0 warning letters, 20 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Angiodynamics, Inc.?

The most recent FDA event Argus HQ has on file for Angiodynamics, Inc. is dated 2026-04-29, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Angiodynamics, Inc. — FDA Compliance Timeline

At a glance: Argus HQ has recorded 20 FDA events for Angiodynamics, Inc.: 0 warning letters, 20 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-04-29 to 2026-04-29. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	20
Warning letters	0
Recalls	20
Approval records	0
Form 483 inspection citations	0
Most recent action	April 29, 2026

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Angiodynamics, Inc. has 20 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event.

Enforcement history

On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: Soft-Vu Angiographic Catheter, Kumpe, Non-Braided; SOFT-VU KMP 4F X 65CM 038 NB… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: AccuVu Angiographic Catheter, Omni Flush, Non-Braided, With 21 R/O Markers; ACC… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: AccuVu Angiographic Catheter, Straight Flush, Non-Braided, With 10 R/O Markers;… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: Soft-Vu Angiographic Catheter, Kumpe, Non-Braided; SOFT-VU KMP 4F X 100CM 038 N… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: AccuVu Angiographic Catheter, Pigtail, Non-Braided, With 21 R/O Markers; ACCU-V… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: Soft-Vu Angiographic Catheter, Omni Flush, Non-Braided; SOFT-VU OF 4F X 65CM 03… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: Soft-Vu Angiographic Catheter, Pigtail, Non-Braided; SOFT-VU PT 4F X 100CM 035… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: Soft -Vu Angiographic Catheter, Kumpe, Non-Braided; SOFT-VU KMP 4F X 40CM 038 N… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: Soft-Vu Angiographic Catheter, Berenstein, Non-Braided; SOFT-VU BER 4F X 100CM… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Angiodynamics, Inc., rated "high" severity in Argus HQ's classification: Angiodynamics, Inc. — Class II recall: Soft-Vu.

Frequently asked questions

Has Angiodynamics, Inc. had product recalls?: Yes, 20 recalls on file. See the full history below for each one.
Is this FDA enforcement data for Angiodynamics, Inc. official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
How many FDA actions has Angiodynamics, Inc. had?: Argus HQ has recorded 20 FDA events for Angiodynamics, Inc.: 0 warning letters, 20 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
What is the most recent FDA action against Angiodynamics, Inc.?: The most recent FDA event Argus HQ has on file for Angiodynamics, Inc. is dated 2026-04-29, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Angiodynamics, Inc. — FDA Compliance Timeline. Digital Empire LLC. Retrieved from https://argushq.ai/company/angiodynamics-inc

MLA

"Angiodynamics, Inc. — FDA Compliance Timeline." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/angiodynamics-inc.

Chicago

Argus HQ Research. "Angiodynamics, Inc. — FDA Compliance Timeline." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/angiodynamics-inc.

BibTeX

@misc{argushq_argushq_ai_company_angiodynamics_inc_2026,
  title = {Angiodynamics, Inc. — FDA Compliance Timeline},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/angiodynamics-inc},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗